Search by Drug Name or NDC

    NDC 00002-1200-30 Amyvid 51 mCi/mL Details

    Amyvid 51 mCi/mL

    Amyvid is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eli Lilly and Company. The primary component is FLORBETAPIR F-18.

    Product Information

    NDC 00002-1200
    Product ID 0002-1200_c2f899b5-287a-4002-ae37-f69418174eb4
    Associated GPIs
    GCN Sequence Number 069224
    GCN Sequence Number Description florbetapir F-18 VIAL 10 MCI INTRAVEN
    HIC3 H1Y
    HIC3 Description DIAGNOSTIC RADIOPHARM - AMYLOID/TAU IMAGING
    GCN 32177
    HICL Sequence Number 039020
    HICL Sequence Number Description FLORBETAPIR F-18
    Brand/Generic Brand
    Proprietary Name Amyvid
    Proprietary Name Suffix n/a
    Non-Proprietary Name Florbetapir F 18
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 51
    Active Ingredient Units mCi/mL
    Substance Name FLORBETAPIR F-18
    Labeler Name Eli Lilly and Company
    Pharmaceutical Class Positron Emitting Activity [MoA], Radioactive Diagnostic Agent [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA202008
    Listing Certified Through 2024-12-31

    Package

    NDC 00002-1200-30 (00002120030)

    NDC Package Code 0002-1200-30
    Billing NDC 00002120030
    Package 1 VIAL, MULTI-DOSE in 1 CAN (0002-1200-30) / 30 mL in 1 VIAL, MULTI-DOSE
    Marketing Start Date 2012-06-01
    NDC Exclude Flag N
    Pricing Information N/A